Instruction for use: Dexona

Active substance: Dexamethasone

ATX Code H02AB02 Dexamethasone

Pharmacological group

Glucocorticosteroids

The nosological classification (ICD-10)

G93.6 Edema of the brain

Intraoperative cerebral edema, Cerebral edema, Post-traumatic swelling of the brain, Brain edema associated with radiation therapy, Brain edema associated with head trauma, Post-traumatic cerebral edema, Edema of the brain in poisoning

I00 Rheumatic fever without mention of cardiac involvement

Acute rheumatism, Rheumatic arthritis acute, Rheumatism is active, Rheumatic fever, Acute attack of rheumatic joint disease

I01 Rheumatic fever with involvement of the heart

Rheumatic carditis acute

J98.8.0 * Bronchospasm

Bronchospasm in bronchial asthma, Bronchospasm when exposed to an allergen, bronchospastic reactions, bronchospastic status, bronhospastichesky syndrome, Diseases accompanied by bronchospastic syndrome, reversible bronchospasm, spasmodic cough

L10 Pemphigus [pemphigus]

Benign pemphigoid of mucous membranes, Bubble dermatosis, Pemphigus, Dermatitis, vesicular, Benign pemphigus, Ordinary pemphigus, Pemphigus, Bubble dermatitis, Family benign pemphigus Hailey-Hailey

T78.2 Anaphylactic shock, unspecified

Anaphylactic shock, Anaphylactoid reaction, Anaphylactic shock, Anaphylactic reactions, Anaphylactic shock to drugs

Composition and form of release

1 tablet contains dexamethasone 0.5 mg; In contour non-jawed packaging 10 pcs.

1 ml solution for injection - dexamethasone sodium phosphate 4 mg; In bottles of 2 ml, in the outline of the cell 6 bottles.

Eye / ear drops contain dexamethasone sodium phosphate 0.1%, neomycin sulfate 0.5%, benzalkonium chloride 0.02%; In bottles of dark glass to 5 ml complete with a dropper, in a cardboard bundle 1 bottle.

pharmachologic effect

Pharmacological action - anti-inflammatory.

indications

Tablets: rheumatoid arthritis, allergic reactions, bronchial asthma, dermatological diseases, acute ulcerative colitis, rheumatic fever, disseminated lupus erythematosus, nephrotic syndrome, malignant diseases.

Solution for injection: anaphylactic shock, cerebral edema, bronchospasm, pemphigus.

Eye / ear drops: allergic and inflammatory diseases (including microbial) of the eye and ears: conjunctivitis, herpes zoster, otitis, iridocyclitis, sympathetic ophthalmia, scleritis, allergic blepharitis.

Contraindications

Tablets, solution for injection: systemic fungal and viral infections.

Eye / ear drops: hypersensitivity, tuberculosis of the eyes and ears, perforation of the tympanic membrane.

Application in pregnancy and lactation

Perhaps, if the expected effect of therapy exceeds the potential risk to the fetus.

Side effects

Dizziness, headache, menstrual irregularities, muscle weakness, sodium retention, hypertension; Drops: cataract, glaucoma, secondary eye infections.

Dosing and Administration

Tablets: Inside, 3 mg / day (up to 4-6 mg / day). The maintenance dose is 0.5-1 mg / day in 2-4 admission.

Solution for injection: intravenously slowly (4-5 minutes), IM (intramuscularly), IV infusion - 1-5 ml (4-20 mg) 3-4 times a day.

Drops of the eye / ear: 1-2 drops 3-4 times a day in the eye, 3-4 drops in the affected ear 2-3 times a day.

Precautionary measures

With caution appoint with peptic ulcer of the stomach and duodenum.

storage conditions

At a temperature of 15-30 ° C.

Keep out of the reach of children.

Shelf-life of Dexona

Tablets 0.5 mg - 4 years.

Drops eye and ear - 3 years.

Injection for 4 mg / ml - 3 years.

Do not use after the expiry date printed on the package.